rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: cadila pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler cadila pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 3 mg/1

Manufacturer
Cadila Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 71209-013
Product ID 71209-013_862f0b42-695e-4170-983d-cfb848967cf3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203844
Listing Expiration 2026-12-31
Marketing Start 2014-02-11

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71209013
Hyphenated Format 71209-013

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0371209012034 0371209014038 0371209013031
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA203844 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (71209-013-03)
  • 500 CAPSULE in 1 BOTTLE (71209-013-10)
source: ndc

Packages (2)

71209-013-03 60 CAPSULE in 1 BOTTLE (71209-013-03) 71209-013-10 500 CAPSULE in 1 BOTTLE (71209-013-10)

Ingredients (1)

rivastigmine tartrate (3 mg/1)

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "862f0b42-695e-4170-983d-cfb848967cf3", "openfda": {"upc": ["0371209012034", "0371209014038", "0371209013031"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["e7e641fe-39bd-4681-a430-6dedeb6d6af5"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71209-013-03)", "package_ndc": "71209-013-03", "marketing_start_date": "20140211"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (71209-013-10)", "package_ndc": "71209-013-10", "marketing_start_date": "20140211"}], "brand_name": "Rivastigmine Tartrate", "product_id": "71209-013_862f0b42-695e-4170-983d-cfb848967cf3", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "71209-013", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "3 mg/1"}], "application_number": "ANDA203844", "marketing_category": "ANDA", "marketing_start_date": "20140211", "listing_expiration_date": "20261231"}